Anupam Rasayan Appoints Hetvi Vyas as Deputy CFO and Key Managerial Personnel
NiveshIQ
NSE: ANURAS · Chemicals
Anupam Rasayan India Ltd.
₹1,219.40▼ ₹11.70 (-0.95%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on ANURAS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Anupam Rasayan India Ltd.
Anupam Rasayan India Ltd (ANURAS) specializes in custom synthesis and manufacturing of specialty chemicals across India, Europe, Japan, Singapore, China, and North America, operating through Life Science and Other Specialty Chemicals segments. The Life Science arm supplies agro intermediates, agro active ingredients, anti‑bacterial and UV protection intermediates for personal care, and key starting materials for active pharmaceutical ingredients, while the Other Specialty Chemicals segment offers pigments, dyes, and polymer additives. In FY25 the company reported revenue of ₹2,535 crore and net income of ₹175 crore, reflecting a 65% surge in earnings driven by higher demand for agro and pharmaceutical intermediates. Recent developments include a ₹60.88 crore stake acquisition in Tanfac Ind
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,475 Cr -7.90% | ₹1,437 Cr -2.60% | ₹2,365 Cr +64.60% |
| EBITDA Margin | 25.76% | 27.89% | 22.96% |
| Net Profit | ₹167.00 Cr -23.00% | ₹160.00 Cr -4.20% | ₹222.20 Cr +38.90% |
| EPS | ₹11.72 | ₹8.49 | ₹15.09 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Anupam Rasayan Promoter Releases Pledge on 42.49 Lakh Equity Shares
Anupam Rasayan India schedules 23rd AGM for September 30
🔒
+ 3 more stories about Anupam Rasayan India Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹655 Cr, PAT ₹51 Cr, EPS ₹3.39, EBITDA margin 26.7%. Growth context: revenue QoQ +3.0%, PAT QoQ -8.6%. Street verdict: strong beat, revenue surprise +24.9%.
Management highlights new capacity additions, capex deployment, order wins, deal pipeline, and backlog build as the prim...
FY26 (last completed FY): revenue ₹2, 365 Cr, PAT ₹222 Cr, EBITDA margin 23.0%, EPS ₹15.09. Year-on-year: revenue YoY +6...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for ANURAS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track ANURAS alongside your other holdings
Unlock full ANURAS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Anupam Rasayan India Ltd.?
NiveshIQ detects active intelligence signals for Anupam Rasayan India Ltd. (ANURAS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Anupam Rasayan India Ltd.?
Anupam Rasayan India Ltd. operates in the Chemicals sector with a market capitalisation of ₹1,558,583.4L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.